Report Detail
Global Pneumococcal Vaccination Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4652796 |
- 05 December, 2025 |
- Global |
- 93 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Pneumococcal Vaccination market size was valued at US$ 9901 million in 2024 and is forecast to a readjusted size of USD 19620 million by 2031 with a CAGR of 10.4% during review period.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
The pneumococcal vaccination market is driven by the increasing awareness of the importance of vaccination and the rising incidence of pneumococcal infections. Pneumococcal vaccines are crucial in preventing diseases caused by Streptococcus pneumoniae bacteria, such as pneumonia, meningitis, and bacteremia. The rise in the geriatric population and the need for immunization against respiratory infections contribute to market growth as pneumococcal vaccines offer significant benefits in reducing morbidity and mortality. Moreover, advancements in vaccine technology, such as the introduction of conjugate vaccines for broader protection, have improved vaccine efficacy. However, the market also faces challenges, including vaccine supply constraints and the need for continuous research to address emerging pneumococcal serotypes and strains. Additionally, addressing vaccine hesitancy and increasing vaccination coverage in underserved populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable pneumococcal vaccines, collaborate with healthcare providers to promote vaccination recommendations, and address the challenges to meet the increasing demand for effective and accessible protection against pneumococcal infections.
This report is a detailed and comprehensive analysis for global Pneumococcal Vaccination market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pneumococcal Vaccination market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Pneumococcal Vaccination market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Pneumococcal Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Pneumococcal Vaccination market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pneumococcal Vaccination
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pneumococcal Vaccination market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, GSK, MSD, CDIBP, WALVAX, Sinovac, Bio Kangtai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pneumococcal Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
PPSV 23
PCV 13
PCV 10
Market segment by Application
Child
Adult
Major players covered
Pfizer
GSK
MSD
CDIBP
WALVAX
Sinovac
Bio Kangtai
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pneumococcal Vaccination product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccination, with price, sales quantity, revenue, and global market share of Pneumococcal Vaccination from 2020 to 2025.
Chapter 3, the Pneumococcal Vaccination competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccination breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pneumococcal Vaccination market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pneumococcal Vaccination.
Chapter 14 and 15, to describe Pneumococcal Vaccination sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Pneumococcal Vaccination Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 PPSV 23
- 1.3.3 PCV 13
- 1.3.4 PCV 10
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Pneumococcal Vaccination Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Child
- 1.4.3 Adult
- 1.5 Global Pneumococcal Vaccination Market Size & Forecast
- 1.5.1 Global Pneumococcal Vaccination Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Pneumococcal Vaccination Sales Quantity (2020-2031)
- 1.5.3 Global Pneumococcal Vaccination Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Pfizer
- 2.1.1 Pfizer Details
- 2.1.2 Pfizer Major Business
- 2.1.3 Pfizer Pneumococcal Vaccination Product and Services
- 2.1.4 Pfizer Pneumococcal Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Pfizer Recent Developments/Updates
- 2.2 GSK
- 2.2.1 GSK Details
- 2.2.2 GSK Major Business
- 2.2.3 GSK Pneumococcal Vaccination Product and Services
- 2.2.4 GSK Pneumococcal Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 GSK Recent Developments/Updates
- 2.3 MSD
- 2.3.1 MSD Details
- 2.3.2 MSD Major Business
- 2.3.3 MSD Pneumococcal Vaccination Product and Services
- 2.3.4 MSD Pneumococcal Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 MSD Recent Developments/Updates
- 2.4 CDIBP
- 2.4.1 CDIBP Details
- 2.4.2 CDIBP Major Business
- 2.4.3 CDIBP Pneumococcal Vaccination Product and Services
- 2.4.4 CDIBP Pneumococcal Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 CDIBP Recent Developments/Updates
- 2.5 WALVAX
- 2.5.1 WALVAX Details
- 2.5.2 WALVAX Major Business
- 2.5.3 WALVAX Pneumococcal Vaccination Product and Services
- 2.5.4 WALVAX Pneumococcal Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 WALVAX Recent Developments/Updates
- 2.6 Sinovac
- 2.6.1 Sinovac Details
- 2.6.2 Sinovac Major Business
- 2.6.3 Sinovac Pneumococcal Vaccination Product and Services
- 2.6.4 Sinovac Pneumococcal Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Sinovac Recent Developments/Updates
- 2.7 Bio Kangtai
- 2.7.1 Bio Kangtai Details
- 2.7.2 Bio Kangtai Major Business
- 2.7.3 Bio Kangtai Pneumococcal Vaccination Product and Services
- 2.7.4 Bio Kangtai Pneumococcal Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Bio Kangtai Recent Developments/Updates
3 Competitive Environment: Pneumococcal Vaccination by Manufacturer
- 3.1 Global Pneumococcal Vaccination Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Pneumococcal Vaccination Revenue by Manufacturer (2020-2025)
- 3.3 Global Pneumococcal Vaccination Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Pneumococcal Vaccination by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Pneumococcal Vaccination Manufacturer Market Share in 2024
- 3.4.3 Top 6 Pneumococcal Vaccination Manufacturer Market Share in 2024
- 3.5 Pneumococcal Vaccination Market: Overall Company Footprint Analysis
- 3.5.1 Pneumococcal Vaccination Market: Region Footprint
- 3.5.2 Pneumococcal Vaccination Market: Company Product Type Footprint
- 3.5.3 Pneumococcal Vaccination Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Pneumococcal Vaccination Market Size by Region
- 4.1.1 Global Pneumococcal Vaccination Sales Quantity by Region (2020-2031)
- 4.1.2 Global Pneumococcal Vaccination Consumption Value by Region (2020-2031)
- 4.1.3 Global Pneumococcal Vaccination Average Price by Region (2020-2031)
- 4.2 North America Pneumococcal Vaccination Consumption Value (2020-2031)
- 4.3 Europe Pneumococcal Vaccination Consumption Value (2020-2031)
- 4.4 Asia-Pacific Pneumococcal Vaccination Consumption Value (2020-2031)
- 4.5 South America Pneumococcal Vaccination Consumption Value (2020-2031)
- 4.6 Middle East & Africa Pneumococcal Vaccination Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Pneumococcal Vaccination Sales Quantity by Type (2020-2031)
- 5.2 Global Pneumococcal Vaccination Consumption Value by Type (2020-2031)
- 5.3 Global Pneumococcal Vaccination Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Pneumococcal Vaccination Sales Quantity by Application (2020-2031)
- 6.2 Global Pneumococcal Vaccination Consumption Value by Application (2020-2031)
- 6.3 Global Pneumococcal Vaccination Average Price by Application (2020-2031)
7 North America
- 7.1 North America Pneumococcal Vaccination Sales Quantity by Type (2020-2031)
- 7.2 North America Pneumococcal Vaccination Sales Quantity by Application (2020-2031)
- 7.3 North America Pneumococcal Vaccination Market Size by Country
- 7.3.1 North America Pneumococcal Vaccination Sales Quantity by Country (2020-2031)
- 7.3.2 North America Pneumococcal Vaccination Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Pneumococcal Vaccination Sales Quantity by Type (2020-2031)
- 8.2 Europe Pneumococcal Vaccination Sales Quantity by Application (2020-2031)
- 8.3 Europe Pneumococcal Vaccination Market Size by Country
- 8.3.1 Europe Pneumococcal Vaccination Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Pneumococcal Vaccination Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Pneumococcal Vaccination Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Pneumococcal Vaccination Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Pneumococcal Vaccination Market Size by Region
- 9.3.1 Asia-Pacific Pneumococcal Vaccination Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Pneumococcal Vaccination Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Pneumococcal Vaccination Sales Quantity by Type (2020-2031)
- 10.2 South America Pneumococcal Vaccination Sales Quantity by Application (2020-2031)
- 10.3 South America Pneumococcal Vaccination Market Size by Country
- 10.3.1 South America Pneumococcal Vaccination Sales Quantity by Country (2020-2031)
- 10.3.2 South America Pneumococcal Vaccination Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Pneumococcal Vaccination Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Pneumococcal Vaccination Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Pneumococcal Vaccination Market Size by Country
- 11.3.1 Middle East & Africa Pneumococcal Vaccination Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Pneumococcal Vaccination Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Pneumococcal Vaccination Market Drivers
- 12.2 Pneumococcal Vaccination Market Restraints
- 12.3 Pneumococcal Vaccination Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Pneumococcal Vaccination and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Pneumococcal Vaccination
- 13.3 Pneumococcal Vaccination Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Pneumococcal Vaccination Typical Distributors
- 14.3 Pneumococcal Vaccination Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Pneumococcal Vaccination. Industry analysis & Market Report on Pneumococcal Vaccination is a syndicated market report, published as Global Pneumococcal Vaccination Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Pneumococcal Vaccination market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
